資料載入中.....
|
請使用永久網址來引用或連結此文件:
https://irlib.pccu.edu.tw/handle/987654321/35929
|
| 題名: | Rosiglitazone activation of PPAR gamma-dependent pathways is neuroprotective in human neural stem cells against amyloid-beta-induced mitochondrial dysfunction and oxidative stress |
| 作者: | Chiang, MC (Chiang, Ming-Chang)
Nicol, CJ (Nicol, Christopher J.)
Cheng, YC (Cheng, Yi-Chuan)
Lin, KH (Lin, Kuan-Hung)
Yen, CH (Yen, Chia-Hui)
Lin, CH (Lin, Chien-Hung) |
| 貢獻者: | 生科所 |
| 關鍵詞: | PPAR gamma
PGC1 alpha
hNSCs
A beta |
| 日期: | 2016-04 |
| 上傳時間: | 2017-04-14 13:48:18 (UTC+8) |
| 摘要: | Neuronal cell impairment, such as that induced by amyloid-beta (A beta) protein, is a process with limited therapeutic interventions and often leads to long-term neurodegeneration common in disorders such as Alzheimer's disease. Interestingly, peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-activated nuclear receptor whose ligands control many physiological and pathologic processes, and may be neuroprotective. We hypothesized that rosiglitazone, a PPAR gamma agonist, would prevent A beta-mediated effects in human neural stem cells (hNSCs). Here, we show that rosiglitazone reverses, via PPAR gamma-dependent downregulation of caspase 3 and 9 activity, the A beta-mediated decreases in hNSC cell viability. In addition, A beta decreases hNSC messenger RNA (mRNA) levels of 2 neuroprotective factors (Bcl-2 and CREB), but co-treatment with rosiglitazone significantly rescues these effects. Rosiglitazone co-treated hNSCs also showed significantly increased mitochondrial function (reflected by levels of adenosine triphosphate and Mit mass), and PPAR gamma-dependent mRNA upregulation of PGC1 alpha and mitochondrial genes (nuclear respiratory factor-1 and Tfam). Furthermore, hNSCs co-treated with rosiglitazone were significantly rescued from A beta-induced oxidative stress and correlates with reversal of the A beta-induced mRNA decrease in oxidative defense genes (superoxide dismutase 1, superoxide dismutase 2, and glutathione peroxidase 1). Taken together, these novel findings show that rosiglitazone-induced activation of PPAR gamma-dependent signaling rescues A beta-mediated toxicity in hNSCs and provide evidence supporting a neuroprotective role for PPAR gamma activating drugs in A beta-related diseases such as Alzheimer's disease. (C) 2016 Elsevier Inc. All rights reserved. |
| 關聯: | NEUROBIOLOGY OF AGING 卷: 40 頁碼: 181-190 |
| 顯示於類別: | [生物科技研究所 ] 期刊論文
|
文件中的檔案:
| 檔案 |
描述 |
大小 | 格式 | 瀏覽次數 |
|---|
| index.html | | 0Kb | HTML | 352 | 檢視/開啟 |
|
在CCUR中所有的資料項目都受到原著作權保護.
|
